Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 12—December 2008
Letter

Human Salmonella Infection Yielding CTX-M β-Lactamase, United States

Maria Sjölund-KarlssonComments to Author , Jennifer Yam, Jillian Schwenk, Kevin Joyce, Felicita Medalla, Ezra Barzilay, and Jean M. Whichard
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Sjölund, J. Yam, J. Schwenk, K. Joyce, F. Medalla, E. Barzilay, J.M. Whichard); Atlanta Research and Education Foundation, Atlanta (M. Sjölund, J. Yam, K. Joyce)

Main Article

Table

MIC values of antimicrobial drugs for the Salmonella ser. Typhimurium isolate and its Escherichia coli DH10B transformant

Antimicrobial agent MIC, mg/L
S. ser. Typhimurium E. coli DH10B transformant E. coli DH10B
Amikacin 1 1 1
Amoxicillin–clavulanic acid 32 16 4
Ampicillin >32 >32 4
Aztreonam 32 32 0.12
Cefepime 32 32 <0.06
Cefotaxime >64 >64 <0.06
Cefotaxime–clavulanic acid 0.25 0.12 <0.06
Cefoxitin 2 8 8
Cefquinome >32 >32 <0.06
Ceftazidime 8 8 0.5
Ceftazidime–clavulanic acid 0.5 0.25 0.12
Ceftiofur >8 >8 0.5
Ceftriaxone >64 >64 <0.25
Chloramphenicol >32 <2 <2
Ciprofloxacin <0.016 <0.016 <0.016
Gentamicin 4 <0.25 <0.25
Imipenem 0.5 0.25 0.25
Kanamycin >64 <8 <8
Nalidixic acid 4 1 1
Piperacillin-tazobactam >64 2 2
Streptomycin <32 >64 >64
Sulfisoxazole >256 <16 <16
Tetracycline >32 <4 <4
Trimethoprim-sulfamethoxazole >4 <0.12 <0.12

Main Article

Page created: July 22, 2010
Page updated: July 22, 2010
Page reviewed: July 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external